Baiyu pharmaceutical takes internationalization as an important development strategy of the enterprise and actively promotes the modernization and internationalization of traditional Chinese medicine. Ginkgo biloba, represented by ginkgolide injection, has brought new options for stroke patients. It has been registered in Vietnam, Malaysia and other Southeast Asian countries, and actively expanded to Brazil, Chile, Peru and other emerging markets. In addition, phase III clinical trials of Ginkgolide Dropping Pills have been carried out in China, which will benefit more patients at home and abroad after approval.